|
HS Code |
549729 |
| Iupac Name | (S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |
| Molecular Formula | C19H21NOS |
| Molecular Weight | 311.44 g/mol |
| Cas Number | 78916-67-9 |
| Appearance | White to off-white solid |
| Melting Point | 118-120 °C |
| Solubility | Soluble in DMSO and ethanol |
| Optical Activity | Chiral, (S)-enantiomer |
| Purity | Typically ≥98% (HPLC) |
| Storage Temperature | 2-8 °C (refrigerated) |
| Synonyms | (S)-(+)-N,N-Dimethyl-3-(1-naphthyloxy)-3-(2-thienyl)propanamine |
As an accredited (S)-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)Propanamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 1-gram amber glass vial, sealed, labeled with name, formula, CAS number, and safety information. |
| Shipping | This chemical, (S)-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)Propanamine, is shipped in tightly sealed, chemical-resistant containers, ensuring protection from light and moisture. Packaging complies with international regulations for hazardous substances, using cushioned secondary containment. Shipping is via tracked, express courier, with documentation for safe handling and regulatory compliance. |
| Storage | (S)-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)propanamine should be stored in a tightly sealed container, in a cool, dry, well-ventilated area, away from sources of heat, moisture, and ignition. Protect from light and incompatible materials such as strong oxidizers and acids. Store at room temperature or as specified by the manufacturer. Ensure proper labeling and follow local chemical storage regulations. |
Applications of (S)-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)Propanamine in Industrial ManufacturingAs a direct producer, we deliver (S)-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)Propanamine for targeted downstream chemical manufacturing. Our multi-step synthesis enables stringent impurity control, supporting various industries with gold-standard raw material for high-value production environments. 1. Active Pharmaceutical Ingredient (API) Synthesis for Antidepressant MedicationsThis intermediate serves in the synthesis of selective serotonin and norepinephrine reuptake inhibitors, specifically contributing to chiral pharmaceutical APIs. Final customers utilize this material during multi-stage API assembly requiring high enantiomeric purity. The compound supports tangible batch reproducibility and documented traceability demands in regulated API plants. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Precursor for Advanced Organic Electronic MaterialsThe compound acts as a functionalized amine donor in the synthesis of organic semiconductors. Electronic materials firms use this intermediate for coupling and cyclization processes targeting small-molecule or oligomeric electronic devices. These organic compounds, with rigid planar moieties, undergo further elaboration to form charge transfer complexes or emissive OLED layers with high purity demand. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chiral Solvating Agent Development for Analytical LaboratoriesOur product enters the specialty chemicals sector as a high-purity chiral solvating agent base for NMR chiral discrimination. End users develop analytical tools capable of enantiomeric excess quantification in pharmaceutical and fine chemical quality control labs. Batch-specific quality certificates accompany every shipment, supporting reproducibility in stereochemistry analysis pipelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Research-Grade Reagent for CNS Drug Discovery ProjectsSpecialty research organizations and medicinal chemistry divisions utilize this compound as a high-activity amine in SAR (structure-activity relationship) libraries. It is supplied for direct use in combinatorial chemistry, facilitating compound screening against neural targets. All shipments undergo full analytical documentation, supporting lead optimization cycles and patent filings in CNS discovery programs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (S)-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)Propanamine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Peering down the long rows of glass-lined reactors and gleaming stainless steel, I remember the early days working with complex chiral amines. Back then, hitting high optical purity on every batch challenged every decision and demanded patience. Years later, we saw the medical sector looking for more selective serotonin-norepinephrine reuptake inhibitors, and synthetic teams everywhere started chasing fine-tuned analogues of compounds that evolved into names like duloxetine. That journey led us straight to developing `(S)-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)Propanamine`, and each cycle taught us what matters most in the chemistry, not just the finished product in a jar.
This compound stands out with its dual aromatic core—naphthalene and thiophene. That unique architecture gives it more than marketable chirality. You can draw its structure out, and right there, the placement of the oxygen atom bridging the naphthyl to the main propanamine backbone reveals why this molecule behaves the way it does. Chemically, you get a strong potential for hydrogen bonding, a balance between rigidity and flexibility, and a lipophilic signature from both ring systems. In the hands of a skilled synthetic chemist, that means more options during analog development or salt formation.
Over years at the bench, we learned neatness at small scales does not always survive kilo-lab execution. That led us to invest in chiral resolution techniques that don’t destroy yield or complicate downstream handling. Our current approach controls stereochemistry tightly, with (S)-enantiomeric excess routinely exceeding 99%. That metric matters in industry work. Many downstream applications—particularly in central nervous system research—demand tight control, since biological receptors show strong enantioselectivity. Our output comes out clean, no racemic soup mixed in, so nobody down the line sees headaches from batch variability.
We run our product process at multi-kilo scale, choosing DMF or acetonitrile for certain steps to grant us clean cleavages and minimal byproducts. Over time, lab monitoring has built trust within our team—every appearance of an unexpected spot on a TLC brings out the old hands to check what went sideways. We use HPLC for chiral purity and NMR for full spectrum checks; each batch gets certified before release. The specifications you see from us haven’t been pieced together from standard compendia or third-hand guesses. Each one has been hammered out against real issues we faced: a sticky residue fouling one filter, or a troublesome intermediate gumming up a crystallizer.
Color, melting point, and solubility all reflect the latest tweaks we’ve made. Any slight yellow tint flagged by our team usually points to traces of oxidized thiophene byproducts. We learned how to spot that long before anyone downstream found a problem.
This molecule’s main story sits squarely within the pharmaceutical world, especially for groups searching for improved anti-depressant and pain management agents. Because of the methoxy bridge and presence of both a naphthalenyloxy and thienyl group, the structure delivers strong binding to serotonin-norepinephrine transporters. That pushes it into the same chemical conversation as duloxetine. Years back, our partners faced import holdups and regulatory questioning over suspect batches from distant suppliers. Ever since, we’ve taken pride in suspending production if so much as a single analytic peak goes unexplained.
We manufacture for both research-scale buyers and bulk demand. Pharmaceutical labs rely on our chemical to develop pure reference standards. Academic teams—sometimes under daunting budget pressure—have used our product to probe structure-activity relationships. For every kilogram that leaves our site, we retain multiple retained samples, and we’ve tracked every significant batch deviation. So, marketing gloss aside, the trust from years of transparent, candid reporting means more to us than big claims.
Getting the right form of a compound means more than matching a spec sheet. The solid state—fine powder or crystalline—can change batch consistency, and we have seen many labs face bottlenecks when a supplier delivers product with off-spec particle size. Our routine includes particle size analysis, not just by sieve but with laser diffraction, so what ships matches the requirements set out by the customer’s downstream applications.
Moisture content also can spark headaches. Overexposure to air will sometimes leave this compound clumping due to light hygroscopicity. Best results come packed under nitrogen, in double-sealed HDPE drums or amber glass, depending on batch size. We confirm container closures ourselves, since a minor slip can ruin weeks of work further up the pharma research chain.
Way too often, we’ve seen customers burned by surface-level comparisons: catalog numbers, generic labels, and supposed equivalency. This compound’s chiral center makes all the difference. The (R)-enantiomer, available from some sources, will deliver vastly different biological outcomes, if it acts at all—which means failed trials or wasted research dollars for the end user.
Some traders and brokers will promise a pure product, but too many don’t control storage and humidity as needed. Our direct manufacturing oversight means fewer unknowns—every drum can be traced to raw materials sourced and processed on our watch. Broker-supplied batches sometimes arrive with broad melting point ranges or minor impurities not disclosed up front. We have lost bids by not matching the lowest price, but the customer call back a few months later—after repeat analysis headaches—usually vindicates our tighter controls.
It’s tempting for procurement teams to shave budgets by buying from the lowest or quickest supplier. Every manufacturer faces that pressure. The real savings, though, show up in fewer failed experiments and less lost time. Our batches move from reactor to QA with complete documentation, raw chromatograms, and sample sets accompanying every lot. When a lab hits a snag and needs troubleshooting, we open the door to direct dialogue with the chemists who made the batch. There’s no substitute. On-the-floor knowledge traces the fingerprint of each batch better than any certificate from a distributor halfway across the globe.
Across production, we saw most risks stem from overlooked variables: oxidation, water ingress, residual solvents, and improper temperature exposure. Our team built our batch records and standard operating procedures around these lessons. It means we produce a product that stands on the tests our partners put it through, not just the ones we declare on paper.
Several years working alongside R&D teams have shown that small, avoidable inconsistencies kill more momentum than big, planned setbacks. Getting (S)-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)Propanamine from the same source for years means project teams can draw comparisons without doubting baseline material. Stability studies form a major part of our after-sale support. We monitor retained samples for up to two years and provide real-world shelf stability data, not just theoretical projections.
For firms looking to scale up, our technical support continues well after shipment. When a large pharmaceutical group needs a five-fold increase in batch size, they consult our senior technical staff. Our process scale-up teams have documented where yield drops or impurity profiles shift, advising clear, practical adjustments. This minimizes both financial risk and regulatory downtime during drug development.
Chemical manufacturing does not happen in a vacuum. Every solvent, catalyst, and byproduct needs strict oversight, both for regulatory compliance and environmental stewardship. Our plant uses solvent recovery and waste minimization at every stage. Aqueous washes from the workup step are treated to minimize thienyl degradation contaminants. Ongoing internal audits make sure we comply with safety and emissions standards—to us, these aren’t just boxes to tick, but habits born from having to explain practices to inspectors face-to-face.
Our site-specific regulatory registrations stay current, removing headaches for multinational buyers facing a patchwork of import-specific demands. More than once, we have seen peer companies delayed by missing paperwork or out-of-date analytical files. Years anchoring all paperwork to batch records, instead of secondary digital copies, meant our inventory stood up to scrutiny—domestic or foreign—without hesitation.
Markets reward reliability more than claims. Many labs come back to trusted manufacturers after one brush with opaque supply chains. No matter how refined a process, undetected micro-impurities or batch inconsistencies can sabotage months of research. By keeping our analytics in-house, rapid rechecks happen without delay, and real accountability sits with the same people who built the process from scratch.
Our future plans center on continuous improvement, not just holding the status quo. Every feedback call—whether commending solid performance or raising unexpected complications—feeds into the next revision of our SOPs and targeted investments in equipment or staff training.
Clients often ask what sets this product apart. It’s experience you can measure, not just in assay or optical purity, but in the lived reality of chemical production. Each feature—crisp white powder, tight melting point, high enantiomeric purity—tells the story of work done right, not just work completed. Too often, the difference between a successful project and a stalled pipeline comes down to how well a chemical matches the data on its datasheet, and to us, that starts with every process step under our roof.
Research and development will only demand more rigor as regulatory requirements tighten and market expectations rise. We’ll keep our focus on core values: complete transparency at every stage, responsive technical support, and a relentless pursuit of reliability. For every kilo of (S)-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)Propanamine that leaves our door, the implicit promise runs deeper than purity or price. It means anyone who needs to trust their materials—whether in a cutting-edge pharma lab or a methodical university department—can count on hard-won certainty, not marketing abstraction.